Trento
Copyright policy )Trento
In Trento province 72,4% of women (aged 25-64) are screened regularly, meaning every 3 years. Considering local tariffs and vaccine acquisition cost, the vaccination of 12-year-old girls with a 90% coverage could prevent 8 cases of cervicocarcinoma and 4 related deaths and thus results to be cost-effective (30.267 €/QALY). When the vaccination programme is extended to 16-year-old girls a further 8 cancer cases and 3 deaths could be prevented, with a very similar cost-effectiveness ratio. In Trento province, the net cost for woman vaccinated is 197 € for the single cohort and 199 € for the multiple cohort.
- Università Luigi Bocconi Italy
- GlaxoSmithKline (Italy) Italy
- GlaxoSmithKline (Belgium) Belgium
- University of Pavia Italy
Medicine (General), R5-920, trento, economic & clinical impact, Pharmacoeconomics; Health economics, hpv vaccination, Trento; HPV vaccination; Economic & clinical impact
Medicine (General), R5-920, trento, economic & clinical impact, Pharmacoeconomics; Health economics, hpv vaccination, Trento; HPV vaccination; Economic & clinical impact
selected citations These citations are derived from selected sources.This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).0 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Average influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Average impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Average
Citations provided by BIP!Popularity provided by BIP!